Revista Gastroenterología

November 2021


Disease course in patients with microscopic colitis

Results of a large European inception cohort indicate that a minority of patients with microscopic colitis follow a quiescent disease course whereas the majority suffers from chronic active or relapsing disease with significantly impaired quality of life.


COVID-19 and liver disease

A recent study reveals that chronic liver disease increased the risk of COVID-19-related death in France in 2020. Therapeutic effort limitation may have contributed to COVID-19-related death in patients with a liver-related complication or an alcohol use disorder.

Primary biliary cholangitis (PBC)

Accuracy of transient elastography at diagnosis of PBC (and thus in naive patients) has not been defined. A current study demonstrates that advanced fibrosis can indeed be excluded (liver stiffness measurement ≤ 6.5 kPa) or confirmed (> 11.0 kPa) in many patients in this setting using transient elastography. However, transient elastography is not reliable between these 2 cut-offs, and a liver biopsy may be necessary. BMI and liver biochemistry did not affect transient elastography.

Non-alcoholic fatty liver disease (NAFLD)

There are numerous non-invasive scoring systems for predicting fibrosis in patients with NAFLD. A current study examined the predictive power of these scores for the long-term outcome (risk of fibrosis, liver-related complications, or death). The NAFLD fibrosis score (NFS), hepamet fibrosis score (HFS) and fibrosis 4 index (FIB-4) performed best.

Oesophagus Stomach Duodenum

Helicobacter pylori resistance to antibiotics

European study confirms higher resistance against clarithromycin and levofloxacin in Central/Western and Southern as compared to Northern Europe, which correlates with higher consumption of macrolides and quinolones. These findings should be considered when choosing eradication therapies.


Prevention of post-ERCP pancreatitis

A meta-analysis involving 55 trials and 17,062 patients revealed that rectal diclofenac (100 mg) was the best performing rectal non-steroidal anti-inflammatory drug. Combinations with intravenous fluid therapies or pancreatic stenting may further increase the efficacy.



Login to your account below

Fill the forms bellow to register

Retrieve your password

Please enter your username or email address to reset your password.

Estimado Médico
Para tener acceso a artículos exclusivos de la revista gastroenterología

En su suscripción recibirá mensualmente nuestro boletín con noticias, eventos y sesiones en vivo.

Si ya esta registrado ingrese aquí